Among the companies with shares expected to trade actively in Tuesday's session are Under Armour Inc. (UAA), Teva Pharmaceutical Industries Ltd. (TEVA) and Sprint Corp. (S).

 

After 26 straight quarters of at least 20% revenue growth, Under Armour reported that sales rose just 12% in the holiday quarter and that revenue would rise much less than expected this year. Shares sank 23% to $19.30 in premarket trading.

 

A U.S. federal court ruled against Teva in a patent dispute over its blockbuster multiple-sclerosis drug Copaxone. Teva plans to appeal. Copaxone, an injection for multiple sclerosis, is Teva's most profitable and top-selling product. Shares declined 8.1% to $31.73 premarket.

 

Sprint narrowed its loss in its third fiscal quarter as the wireless carrier continued to grow its customer base, and it now expects to finish the year at the high end of its guidance. Shares rose 2.6% to $9.35 premarket.

 

MasterCard Inc.'s (MA) profit rose in the latest period on a jump in transactions amid its plan to compete in the digital payments space, but revenue growth slowed in the last three months of the year. Shares dropped 2.5% to $106.61 premarket.

 

Coach Inc. (COH) said earnings and revenue rose in the most recent quarter as the retailer pulled back from its struggling North American wholesale business. Shares increased 1% to $36.35 premarket.

 

United Parcel Service Inc. (UPS) said its fourth-quarter sales rose, driven by an uptick in e-commerce deliveries over the holiday season, but lower margins in that business also hurt its bottom line.

 

Pfizer Inc. (PFE) said revenue fell in the fourth quarter, and the company gave an outlook for 2017 revenue below Wall Street's expectations.

 

Harley-Davidson Inc.'s (HOG) retail motorcycle sales slipped 2% worldwide in 2016, dragged down by declines in the U.S. and Latin America.

 

Exxon Mobil Corp. (XOM) reported a 40% decline in profit in the final quarter of the year, as the oil and gas giant booked a hefty charge, though revenue ticked up for the first time after nine straight quarterly declines.

 

Xerox Corp. (XRX) reported profit and revenue declines in its legacy copier business during the fourth quarter, during which it completed its split from the bulk of its services businesses.

 

Health insurer Aetna Inc. (AET) reported a 57% slide in net income, hurt by restructuring costs, even as revenue rose in the fourth quarter.

 

Valero Energy Corp. (VLO) posted quarterly results that beat Wall Street expectations, as downtrodden energy markets show glimmers of a turnaround.

 

AmerisourceBergen Corp. (ABC) unveiled an improved outlook for the current fiscal year as it reported revenue climbed during its fiscal first quarter, with pharmaceutical distribution revenue rising 3.9%.

 

Write to Jenny Roth at jenny.roth@wsj.com and Maria Armental at maria.armental@wsj.com

 

(END) Dow Jones Newswires

January 31, 2017 09:33 ET (14:33 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.
Exxon Mobil (NYSE:XOM)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Exxon Mobil Charts.
Exxon Mobil (NYSE:XOM)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Exxon Mobil Charts.